Literature DB >> 16177304

Conserved structure and function in the granulysin and NK-lysin peptide family.

Charlotte M A Linde1, Susanna Grundström, Erik Nordling, Essam Refai, Patrick J Brennan, Mats Andersson.   

Abstract

Granulysin and NK-lysin are homologous bactericidal proteins with a moderate residue identity (35%), both of which have antimycobacterial activity. Short loop peptides derived from the antimycobacterial domains of granulysin, NK-lysin, and a putative chicken NK-lysin were examined and shown to have comparable antimycobacterial but variable Escherichia coli activities. The known structure of the NK-lysin loop peptide was used to predict the structure of the equivalent peptides of granulysin and chicken NK-lysin by homology modeling. The last two adopted a secondary structure almost identical to that of NK-lysin. All three peptides form very similar three-dimensional (3-D) architectures in which the important basic residues assume the same positions in space. The basic residues in granulysin are arginine, while those in NK-lysin and chicken NK-lysin are a mixture of arginine and lysine. We altered the ratio of arginine to lysine in the granulysin fragment to examine the importance of basic residues for antimycobacterial activity. The alteration of the amino acids reduced the activity against E. coli to a larger extent than that against Mycobacterium smegmatis. In granulysin, the arginines in the loop structure are not crucial for antimycobacterial activity but are important for cytotoxicity. We suggest that the antibacterial domains of the related proteins granulysin, NK-lysin, and chicken NK-lysin have conserved their 3-D structure and their function against mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177304      PMCID: PMC1230960          DOI: 10.1128/IAI.73.10.6332-6339.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Molecular electroporation: a unifying concept for the description of membrane pore formation by antibacterial peptides, exemplified with NK-lysin.

Authors:  M Miteva; M Andersson; A Karshikoff; G Otting
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

Review 2.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides.

Authors:  Y Shai
Journal:  Biochim Biophys Acta       Date:  1999-12-15

Review 3.  The evolution of mycobacterial pathogenicity: clues from comparative genomics.

Authors:  R Brosch; A S Pym; S V Gordon; S T Cole
Journal:  Trends Microbiol       Date:  2001-09       Impact factor: 17.079

4.  In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis.

Authors:  C M Linde; S E Hoffner; E Refai; M Andersson
Journal:  J Antimicrob Chemother       Date:  2001-05       Impact factor: 5.790

5.  Candidacidal activity of shortened synthetic analogs of amoebapores and NK-lysin.

Authors:  J Andrä; M Leippe
Journal:  Med Microbiol Immunol       Date:  1999-12       Impact factor: 3.402

6.  Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.

Authors:  Z Wang; E Choice; A Kaspar; D Hanson; S Okada; S C Lyu; A M Krensky; C Clayberger
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

7.  Molecular cloning and characterization of equine NK-lysin.

Authors:  Elizabeth G Davis; Yongming Sang; Bonnie Rush; Guolong Zhang; Frank Blecha
Journal:  Vet Immunol Immunopathol       Date:  2005-05-01       Impact factor: 2.046

8.  Identification of an anti-mycobacterial domain in NK-lysin and granulysin.

Authors:  D Andreu; C Carreño; C Linde; H G Boman; M Andersson
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

9.  Spleen antibacterial peptides: high levels of PR-39 and presence of two forms of NK-lysin.

Authors:  V Bonetto; M Andersson; T Bergman; R Sillard; A Norberg; V Mutt; H Jornvall
Journal:  Cell Mol Life Sci       Date:  1999-10-01       Impact factor: 9.261

10.  Granulysin, a T cell product, kills bacteria by altering membrane permeability.

Authors:  W A Ernst; S Thoma-Uszynski; R Teitelbaum; C Ko; D A Hanson; C Clayberger; A M Krensky; M Leippe; B R Bloom; T Ganz; R L Modlin
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

View more
  7 in total

1.  An atomic-force basis for the bacteriolytic effects of granulysin.

Authors:  Yueqin Qiu; An-Bin Hu; Huiyong Wei; Hongying Liao; Shaoyuan Li; Crystal Y Chen; Weihua Zhong; Dan Huang; Jiye Cai; Lifang Jiang; Gucheng Zeng; Zheng W Chen
Journal:  Colloids Surf B Biointerfaces       Date:  2012-05-18       Impact factor: 5.268

2.  Present and future therapeutic strategies for melioidosis and glanders.

Authors:  D Mark Estes; Steven W Dow; Herbert P Schweizer; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

3.  Effects of a single nucleotide polymorphism in the chicken NK-lysin gene on antimicrobial activity and cytotoxicity of cancer cells.

Authors:  Mi Ok Lee; Eun-Hee Kim; Hyun-Jun Jang; Mi Na Park; Hee-Jong Woo; Jae Yong Han; James E Womack
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-10       Impact factor: 11.205

4.  NKLP27: a teleost NK-lysin peptide that modulates immune response, induces degradation of bacterial DNA, and inhibits bacterial and viral infection.

Authors:  Min Zhang; Mo-fei Li; Li Sun
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

5.  Expression of the Bovine NK-Lysin Gene Family and Activity against Respiratory Pathogens.

Authors:  Junfeng Chen; Chingyuan Yang; Polyana C Tizioto; Huan Huang; Mi O K Lee; Harold R Payne; Sara D Lawhon; Friedhelm Schroeder; Jeremy F Taylor; James E Womack
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

Review 6.  Trophic activities of endoplasmic reticulum proteins CDNF and MANF.

Authors:  Maria Jӓntti; Brandon K Harvey
Journal:  Cell Tissue Res       Date:  2020-08-26       Impact factor: 4.051

7.  Human antimicrobial peptides and proteins.

Authors:  Guangshun Wang
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.